Jason Moran
About Jason Moran
Jason Moran serves as the Managing Director and Group Head of Healthcare Investment Banking at KPMG Corporate Finance LLC, where he has worked since 2015. He has extensive experience in investment banking, having held various roles at firms such as Piper Jaffray and Stifel Nicolaus Weisel, and has advised on numerous significant healthcare transactions.
Work at KPMG Corporate Finance LLC
Jason Moran has been serving as Managing Director and Group Head of Healthcare Investment Banking at KPMG Corporate Finance LLC since 2015. In this role, he leads the healthcare life sciences investment banking efforts, focusing on sectors such as biopharmaceuticals, medical technology, tools and diagnostics, and pharma services. Under his leadership, the team has sourced and executed over 20 transactions, representing more than $2 billion in value. His extensive experience in the healthcare sector enables him to provide strategic insights and advisory services to clients.
Previous Experience in Healthcare Investment Banking
Before joining KPMG, Jason Moran held several key positions in healthcare investment banking. He worked at Piper Jaffray from 2001 to 2008, where he progressed from Vice President to Managing Director. He also served as Managing Director at Stifel Nicolaus Weisel from 2008 to 2012. His advisory work includes significant transactions such as the sellside advisory for the acquisition of Renal Services by DaVita and Biocomposites by TA Associates. His career reflects a strong focus on healthcare investment banking.
Education and Expertise
Jason Moran holds a Bachelor of Arts in Biology from Yale University, where he studied from 1992 to 1996. He furthered his education at Stanford University Graduate School of Business, earning a Master of Science in Management from 2013 to 2014. Additionally, he participated in the Stanford Sloan Fellowship program during the same period. His academic background provides him with a solid foundation in both biological sciences and management principles, enhancing his expertise in healthcare investment banking.
Advisory Roles and Transactions
Throughout his career, Jason Moran has acted as an advisor on numerous significant transactions in the healthcare sector. He has served as a sellside advisor for acquisitions including Sividon Diagnostics to Myriad Genetics and Toxikon to Labcorp. He has also been involved in buyside advisory roles, such as the strategic investment of Hitachi High-Tech in Invivoscribe. His experience encompasses a wide range of healthcare companies and transactions, underscoring his expertise in the field.
Early Career and Internships
Jason Moran began his career in investment banking at Banc of America Securities, where he worked as an Associate/Analyst from 1996 to 1999. He also held a brief position as Associate Director of Business Development at Molecular Devices in 1999. Earlier in his career, he completed a summer internship with the CEO of Affymetrix in 1995. These early experiences laid the groundwork for his extensive career in healthcare investment banking.